UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (254) 254
life sciences & biomedicine (249) 249
cardiovascular system & cardiology (185) 185
cardiac & cardiovascular systems (177) 177
humans (169) 169
heart failure (161) 161
male (141) 141
female (140) 140
aged (117) 117
middle aged (110) 110
risk factors (88) 88
heart failure - physiopathology (61) 61
abridged index medicus (58) 58
prognosis (57) 57
heart failure - drug therapy (54) 54
mortality (53) 53
analysis (49) 49
echocardiography (49) 49
treatment outcome (47) 47
cardiovascular (43) 43
prospective studies (43) 43
research (38) 38
aged, 80 and over (34) 34
cardiovascular diseases (33) 33
heart failure with preserved ejection fraction (33) 33
care and treatment (32) 32
double-blind method (32) 32
follow-up studies (32) 32
stroke volume - physiology (32) 32
heart failure - mortality (31) 31
hospitalization (29) 29
peripheral vascular disease (29) 29
time factors (29) 29
clinical trials (28) 28
spironolactone (27) 27
atherosclerosis (26) 26
diabetes (26) 26
united states - epidemiology (26) 26
blood pressure (25) 25
cardiovascular disease (25) 25
heart diseases (25) 25
internal medicine (25) 25
stroke volume (25) 25
hypertension (24) 24
cardiac and cardiovascular systems (22) 22
kardiologi (22) 22
usage (22) 22
adult (20) 20
heart (20) 20
cardiac patients (19) 19
clinical medicine (19) 19
general & internal medicine (19) 19
heart attacks (19) 19
klinisk medicin (19) 19
mineralocorticoid receptor antagonists - therapeutic use (19) 19
patients (19) 19
risk assessment (19) 19
stroke (19) 19
tetrazoles - therapeutic use (19) 19
incidence (18) 18
patient outcomes (18) 18
valsartan (18) 18
aminobutyrates - therapeutic use (17) 17
death (17) 17
health aspects (17) 17
health risk assessment (17) 17
heart failure - epidemiology (17) 17
medical research (17) 17
medicine, general & internal (17) 17
natriuretic peptide, brain - blood (17) 17
proportional hazards models (17) 17
angiotensin receptor antagonists - therapeutic use (16) 16
cardiac output (16) 16
diabetes mellitus (16) 16
dosage and administration (16) 16
heart failure - diagnosis (16) 16
myocardial infarction (16) 16
peptide fragments - blood (16) 16
spironolactone - therapeutic use (16) 16
biomarkers (15) 15
biomarkers - blood (15) 15
clinical trial (15) 15
drug therapy (14) 14
epidemiology (14) 14
retrospective studies (14) 14
cardiology and cardiovascular medicine (13) 13
comparative analysis (13) 13
gastroenterology and hepatology (13) 13
morbidity (13) 13
natriuretic peptides (13) 13
neprilysin (13) 13
online first (13) 13
african americans (12) 12
body mass index (12) 12
heart failure - blood (12) 12
heart failure - complications (12) 12
kaplan-meier estimate (12) 12
medicine, experimental (12) 12
prevalence (12) 12
survival rate - trends (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 04/2014, Volume 370, Issue 15, pp. 1383 - 1392
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2014, Volume 63, Issue 5, pp. 447 - 456
Objectives This study sought to determine the frequency and magnitude of impaired systolic deformation in heart failure with preserved ejection fraction... 
Cardiovascular | Internal Medicine | systolic strain | cardiac biomarkers | mechanics | diastolic heart failure | echocardiography | BRAIN NATRIURETIC PEPTIDE | CARDIAC RESYNCHRONIZATION THERAPY | MYOCARDIAL-INFARCTION | CONTRACTILITY | SOCIETY-OF-CARDIOLOGY | ABNORMALITIES | SPECKLE TRACKING ECHOCARDIOGRAPHY | DEFORMATION | LEFT-VENTRICULAR FUNCTION | DIASTOLIC DYSFUNCTION | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Prognosis | Prospective Studies | Follow-Up Studies | Valsartan | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Valine - analogs & derivatives | Heart Failure - physiopathology | Stroke Volume - physiology | Male | Echocardiography, Doppler, Color - methods | Aminobutyrates - therapeutic use | Heart Failure - drug therapy | Heart Ventricles - physiopathology | Heart Ventricles - ultrastructure | Neprilysin - antagonists & inhibitors | Aged, 80 and over | Female | Tetrazoles - therapeutic use | Valine - therapeutic use | Ventricular Function, Left - physiology | Aged | Heart Failure - diagnostic imaging | Heart failure | Sects | Hypertension | Heart attacks | Mortality | Medical records | Cardiovascular disease | Hospitalization | Family medical history | Fractions | Hospitals | Womens health | Diabetes | Cardiology | Age | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2016, Volume 68, Issue 3, pp. 241 - 248
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 08/2015, Volume 132, Issue 5, pp. 402 - 414
Journal Article
The New England journal of medicine, ISSN 1533-4406, 12/2015, Volume 373, Issue 23, pp. 2247 - 2257
In this randomized study, the addition of lixisenatide, a glucagon-like peptide 1–receptor agonist, to usual care in patients with type 2 diabetes and a recent... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Acute Coronary Syndrome - drug therapy | Myocardial Infarction - complications | Acute Coronary Syndrome - complications | Angina, Unstable - complications | Diabetes Mellitus, Type 2 - mortality | Treatment Failure | Cardiovascular Diseases - epidemiology | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Glucagon-Like Peptide-1 Receptor - agonists | Peptides - adverse effects | Peptides - therapeutic use | Type 2 diabetes | Treatment outcome | Care and treatment | Analysis | Hypoglycemic agents | Dosage and administration | Acute coronary syndrome | Myocardial infarction | Cerebral infarction | Glucagon | Diabetes mellitus | Hypersensitivity | Pancreatitis | Angina | Glucose | Hypoglycemia | Morbidity | Studies | Heart rate | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Pancreas | Drug therapy | Diabetes mellitus (non-insulin dependent) | Heart diseases | Glucagon-like peptide 1 | Clinical trials | Regulatory approval | Hemoglobin | Drug dosages | Heart failure | Mortality | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 08/2018, Volume 19, Issue 8, pp. e377 - e377
Journal Article
Analytical chemistry (Washington), ISSN 0003-2700, 02/2017, Volume 89, Issue 3, pp. 1399 - 1404
Journal Article